Zelira Therapeutics Management
Management criteria checks 4/4
Zelira Therapeutics' CEO is Oludare Odumosu, appointed in Jan 2021, has a tenure of 3.25 years. total yearly compensation is A$478.76K, comprised of 93% salary and 7% bonuses, including company stock and options. directly owns 1.16% of the company’s shares, worth A$93.55K. The average tenure of the management team and the board of directors is 4.3 years and 4.3 years respectively.
Key information
Oludare Odumosu
Chief executive officer
AU$478.8k
Total compensation
| CEO salary percentage | 93.0% |
| CEO tenure | 3.3yrs |
| CEO ownership | 1.2% |
| Management average tenure | 4.3yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Zelira Therapeutics Limited's (ASX:ZLD) CEO Will Probably Find It Hard To See A Huge Raise This Year
Nov 08
Is Zelira Therapeutics (ASX:ZLD) In A Good Position To Invest In Growth?
Jul 14Here's Why Zelira Therapeutics (ASX:ZLD) Must Use Its Cash Wisely
Jan 19Will Zelira Therapeutics (ASX:ZLD) Spend Its Cash Wisely?
Sep 25Will Zelira Therapeutics (ASX:ZLD) Spend Its Cash Wisely?
Jun 03A Quick Analysis On Zelira Therapeutics' (ASX:ZLD) CEO Compensation
Dec 31
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$36m |
| Sep 30 2023 | n/a | n/a | -AU$21m |
| Jun 30 2023 | AU$479k | AU$445k | -AU$6m |
| Mar 31 2023 | n/a | n/a | -AU$8m |
| Dec 31 2022 | n/a | n/a | -AU$10m |
| Sep 30 2022 | n/a | n/a | -AU$11m |
| Jun 30 2022 | AU$642k | AU$449k | -AU$12m |
| Mar 31 2022 | n/a | n/a | -AU$11m |
| Dec 31 2021 | n/a | n/a | -AU$10m |
| Sep 30 2021 | n/a | n/a | -AU$9m |
| Jun 30 2021 | AU$560k | AU$318k | -AU$9m |
| Mar 31 2021 | n/a | n/a | -AU$8m |
| Dec 31 2020 | n/a | n/a | -AU$8m |
| Sep 30 2020 | n/a | n/a | -AU$8m |
| Jun 30 2020 | AU$321k | AU$114k | -AU$7m |
Compensation vs Market: Oludare's total compensation ($USD311.15K) is about average for companies of similar size in the Australian market ($USD290.69K).
Compensation vs Earnings: Oludare's compensation has been consistent with company performance over the past year.
CEO
Oludare Odumosu
3.3yrs
Tenure
AU$478,760
Compensation
Dr. Oludare Odumosu serves as Director of Zelira Therapeutics Limited (formerly Zelda Therapeutics Ltd) since December 02, 2019. He serves as the Managing Director & Global Chief Executive Officer of Zelir...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | 4.3yrs | AU$144.00k | 3.78% A$ 304.5k | |
| MD, Global CEO & Director | 3.3yrs | AU$478.76k | 1.16% A$ 93.6k | |
| Executive Director | no data | AU$253.26k | no data | |
| Company Secretary & Non-Executive Director | 7.5yrs | AU$36.00k | 0.069% A$ 5.6k | |
| Vice President of Finance & Accounting | no data | no data | no data | |
| Clinical Trial Consultant | no data | no data | no data |
4.3yrs
Average Tenure
Experienced Management: ZLD's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | 4.3yrs | AU$144.00k | 3.78% A$ 304.5k | |
| MD, Global CEO & Director | 4.3yrs | AU$478.76k | 1.16% A$ 93.6k | |
| Executive Director | 1.2yrs | AU$253.26k | no data | |
| Company Secretary & Non-Executive Director | 2.3yrs | AU$36.00k | 0.069% A$ 5.6k | |
| Member of Medical Advisory Board | no data | AU$12.00k | 2.22% A$ 179.1k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 8.2yrs | no data | no data | |
| Member of Medical Advisory Board | 8.1yrs | no data | no data | |
| Scientific & Medical Advisory Board | 5.7yrs | no data | no data | |
| Scientific & Medical Advisory Board | 5.7yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | AU$7.77k | no data |
4.3yrs
Average Tenure
Experienced Board: ZLD's board of directors are considered experienced (4.3 years average tenure).